Due to health issues, this site is no longer maintained and will be shut down shortly.

IS:GRANULES Granules India Limited

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally. The company offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other specialty products for oncology. Its APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. Granules India Limited was founded in 1984 and is headquartered in Hyderabad, India.

282.35 INR
As of 03/24/2023

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  India
Country of incorporation:  India
IPO date:  06/20/2005
Stock exchange:    National Stock Exchange O
Exchange country:   India
Market cap:   67,259,232,256 INR
Current dividend yield:   0.55%
Sedol:      BWCGVX9

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy